Editorial
Published on 07 Sep 2022
Editorial: The gut-kidney axis: A potential drug target for treating kidney diseases
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1012890
- 1,796 views
- 4 citations
Type at least 3 characters
656 articles
Original Research
Published on 06 Sep 2022
Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.966645
- 6,845 views
- 19 citations
Review
Published on 02 Sep 2022
Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.970601
- 8,158 views
- 13 citations
Original Research
Published on 02 Sep 2022
Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.950699
- 6,957 views
- 14 citations
Original Research
Published on 02 Sep 2022
Sexual dimorphic response to rituximab treatment: A longitudinal observational study in a large cohort of patients with primary membranous nephropathy and persistent nephrotic syndrome
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.958136
- 5,134 views
- 12 citations
Review
Published on 02 Sep 2022
Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.968226
- 28,874 views
- 37 citations
Original Research
Published on 02 Sep 2022
Ferroptosis induced by iron overload promotes fibrosis in ovarian endometriosis and is related to subpopulations of endometrial stromal cells
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.930614
- 10,691 views
- 25 citations
Original Research
Published on 31 Aug 2022
Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.946165
- 3,232 views
- 7 citations
Original Research
Published on 29 Aug 2022
The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.918385
- 5,804 views
- 10 citations
Review
Published on 29 Aug 2022
Roxadustat: Not just for anemia
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.971795
- 37,852 views
- 37 citations
Original Research
Published on 29 Aug 2022
The progress and prospect of natural components in rhubarb (Rheum ribes L.) in the treatment of renal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.919967
- 4,935 views
- 13 citations
Review
Published on 26 Aug 2022
The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.974361
- 6,000 views
- 13 citations
Original Research
Published on 26 Aug 2022
Inhibition of the IRE1/JNK pathway in renal tubular epithelial cells attenuates ferroptosis in acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.927641
- 5,916 views
- 29 citations
Review
Published on 25 Aug 2022
The critical role of dysregulated autophagy in the progression of diabetic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.977410
- 4,277 views
- 9 citations
Review
Published on 24 Aug 2022
Autophagy in renal fibrosis: Protection or promotion?
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.963920
- 4,262 views
- 13 citations
Original Research
Published on 23 Aug 2022
Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.935937
- 7,437 views
- 16 citations